Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Pfizer Inc Transaction History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD

$385 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $705,177 - $824,282	-21,975 Reduced 29.26%	53,123 $1.76 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $2.71 Million - $3.14 Million	75,098 New	75,098 $2.75 Million

Others Institutions Holding PFE

# of Institutions

3,230

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.68 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.33 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.44 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD, based on Form 13F filings with the SEC.

News

Stay updated on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD with notifications on news.

Account